InventisBio

IPO

益方生物科技(上海)股份有限公司

Public · Shanghai, China · Founded 2013 · $247.0M raised

Headquarters
Shanghai
Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$247.0M
Last Round
$147.0M Series DSep 2020
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

InventisBio is a clinical-stage biotech company with two drugs approved and three candidates in clinical trials, with the most advanced in Phase 3 registration trials in China. Founded by scientists with extensive R&D experience at global pharmaceutical companies, the firm focuses on oncology, metabolic, and autoimmune diseases to address unmet medical needs, with headquarters in Shanghai Pudong and operations in New Jersey.

Summary

InventisBio is a Biotech company based in Shanghai, China, founded in 2013. It has raised $247.0M in total across 4 rounds, most recently a $147.0M Series D round in Sep 2020. Investors include OrbiMed, Hillhouse Capital and Advantech Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DSep 2020
$147.0M

Sign up to see all 4 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

InventisBio on Indexed.vc
<a href="https://indexed.vc/companies/inventisbio"><img src="https://indexed.vc/api/badge/company/inventisbio" alt="InventisBio on Indexed.vc" width="260" height="76" /></a>